Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your point is well taken. Although in retrospect for what little good TOMDF, going bust is like playing Black Jack.
We might have been better giving our lunch money to Gerald Commissiong to go play Black Jack with the promissory note that we get 50% of his winnings.
I understand bad sentiment, but all of his posts puts full blame on Gerald and I've never seen a single post accepting any personal responsibility for the investment decision. Not one. If you know of one, please show us.
Anyone who invests $160K in a OTC penny stock that has never generated a dime of revenue deserves a big heaping pile of that responsibility, no matter what the CEO may have told him. He claims Gerald lied to him. That may be true, but it's on the investor to take every statement and promise with a large degree of skepticism until the business model starts to perform (i.e., partnerships with reputable firms or revenues generated). The fact that none of this occurred with AMBS leaves no other conclusion except this was a very naive or inexperienced investor who let his greed get the best of him, and refuses to own any of it.
Johnny has posted numerous times that SEC filings are the ONLY thing an investor should rely upon, yet that didn't seem to matter in his AMBS investment, and clearly isn't being followed now if you monitor his investment in MONI, where the investment is more driven by rumors, investor call speculations, and insider postings on X, none of which ever show up in their SEC filings. Very hypocritical when one's advice for others isn't applied to their own investments.
I've read enough of the AMBS board and history to know it seemed like a very promising venture at one point, especially when they had the high-caliber medical/scientific team in place. Amarantus Biosciences was started because Gerald wanted to bring his father's key MANF discovery to market. I believe it was all well intended and the the individuals who joined the AMBS ranks clearly saw the potential, too.
In my opinion the company tried to grow too fast while still relying on issuing shares to raise capital instead of focusing on generating actual revenue with existing assets before expanding. That's happened to hundreds, if not thousands of small companies over time. At least TOMDF had growing revenues with their lab business but in an area highly dependent on government testing policy during the pandemic, which ultimately dried up and couldn't be sustained as the cash cow they intended to fund everything else.
I suspect Johnny's leopard will never change its spots and will continue to blame CEOs and insiders for any investment losses incurred, while taking full ownership for any investment wins. Sadly, from my review of posting history, there are few if any wins. Maybe some trading wins from time to time, but overall most investments he chooses are major losers, and continue to head sharply lower every time he averages down with more purchases.
This video exemplifies Johnny's stock picking ability. Johnny is the Colonel Klink of stock picking.
When one loses big money on a rotten investment, it creates really bad sentiment. Resentment for Gerald Commissiong runs high.
I'm sure it was AFTER Gerald twisted his arm and forced him to invest $160,000 in a startup penny stock that had zero revenues. Bad Bad Gerald. No one should ever be forced to invest their daughter's college fund against their will.
Best to let Rotten Johnny explain when he saw the light that Gerald Commissiong was an empty suit.
All said, apologises are in order if I offended anyone. I just want to keep me and my families current $160,000 investment in AMBS "real", and not to go down the proverbial road of drinking the kool aide, as is so prevelent among the OTCBB penny play stocks.
well spoken Warp - trying to re-arrange my portfolio to increase my holdings to 4-Mil. shares in AMBS, double that of what it is right now - thats how confident I am in FY-14 being a platform year - just looking to do it incrementally along with the float - is all
Best to let Rotten Johnny explain when he saw the light that Gerald Commissiong was an empty suit.
Then you need to look further back. I spent many hours looking at his posting history on the AMBS board, as well as listening to audio of the numerous investor calls where he passed himself off as a stock analyst. He had his head so far up Gerald Commissiong's ass he couldn't tell if it was day or night. It was clear he was in direct contact with Gerald and this must have made him feel like he had the "inside scoop" on everything going on with Amarantus.
He was so enamored with Gerald and the team he assembled at Amarantus he invested over six figures in that penny stock that had never generated a dime of revenue yet. Not a smart move for such a "savvy investor" as he thought he was.
I got the impression from reading a lot of the posts on that board and reading into the history of Amarants, that Gerald and his team tried to expand too fast into too many candidate drugs before they ever got anything into clinical trials, or partnered with a larger pharma, and eventually ran out of investor cash. So when things started falling apart, Rotten Johnny blamed Gerald.
But I doubt Gerald twisted his arm or held a gun to his head for that six-figure investment he made in AMBS. Nope, that brilliant move is on Johnny himself, but he will never accept responsibility, but acts like a punk teenager who tried to lie about his investment (and got caught) and blames everyone else but himself for losing all that money. And based on posting to date, he still hasn't learned anything from that experience, except to spew hate and bile about the former CEO.
So yeah, Johnny's a great one to praise. Before he had Gerald's character "correctly assessed", he was lathering praise and congratulations all over Gerald and each member of his team. You should dig up some of those call audio files that I believe are linked on the AMBS board, and listen to what a sucking-up ass-kissing buffoon shareholder sounds like. It might change your mind about your choice to praise this nut.
Well, as far back as I can remember Petro, aka Rotten Johnny, had Gerald Commissiong's character correctly assessed.
Why would I take advice from someone who is a proven liar and manipulator on this board, and who has serious mental issues directed at GC, as bad as anyone currently afflicted with Trump Derangement Syndrome. He claimed to me he never invested six figures in AMBS, never lost money, made gains trading the stock, etc. None of it true, all proven false with his own posts that I dug up. Yet you praise this clown.
https://www.reddit.com/r/TOMDF/comments/sggcka/jpetroinc_warning_avoid_this_deceptive_manipulator/
Just be glad you didn't follow any of his advice on his other investments. One thing he's consistent on... he consistently invests in losers. If Rotten Johnny Petro likes an investment and sees lots of potential there, sell your shares as soon as you can, because all of his investments are total losers, typically with multiple reverse splits and business models based on tossing handfuls of turds at walls to see what might stick. If this is the kind of person you praise, I think you have your own issues.
Regarding the insolvency hearing, I had been communicating with GC and knew the investors he lined up were Israeli. Then the war broke out and I was holding out hope he and Dr. Arad could still close the deal. At that point the share price was already way down and I elected to hold on to see what unfolded. I eventually sold all of my shares before volume dried up completely. Lesson learned, but I don't blame the CEO like some losers do with their investments. Who do you blame? Yourself? The CEO? Me?
You seem to have an infatuation with the fake stock analyst. Did you ever listen to the investor calls he was on for Amarantus, where he made a complete buffoon of himself, congratulating everyone ad nauseam? You should consider following his advice on other stocks.
That's funny that you waited until the insolvency hearing.
You should have taken Rotten Johnny's advice.
You've got to be kidding. My decision to sell was based on my perceived outcome of the insolvency hearing in Israel, not on anything a nutcase former investor with a love/hate relationship with the CEO posted or advised. If you look at the other companies where he posts and invests, all of them are losers. All.
The CEO of those companies must be to blame for the massive losses there as well. Surely not the person who decided to invest in those penny stocks.
But hey, if Rotten Johnny's advice saved you some money and you want to praise him, go right ahead.
We all must praise Rotten Johnny or we might have lost even more money.
long covid brain fog
https://www.upi.com/Health_News/2025/05/15/Long-COVID-patients-show-altered-levels-key-brain-chemicals-study-finds/2651747072883/
Speaking of brain fog--what happened to the john petro guy??--all his trash became "rotten johnny". How does that even happen, and why??
Odd all his other buds, the looney les and oil operation are gone?? Just coincidence I am sure.
Glad his # 1 fan velcro survived to enshrine his hero --John Petrotease
My portfolio investments are 98% dividend stocks long term. The 2% in speculative investments are also long term prospects.
Medical research companies could make a real killing, but normally the investor is killed.
Gerald Commissiong has a history not conducive for long term investors.
I lost a lot of money in Todos as well. But that's behind me and I have a plan to recover it. I won't invest in OTCBB stocks again, and after my current Novavax investment is exited, I won't invest in single stocks again.
I've used the last year to develop an investment method using Robert Lichello's AIM algorithm that I learned about in the 1980's, using leveraged ETFs that have the price volatility to make the model really shine, and significantly reduces risk compared to a buy-and-hold investor.
I have backtested 35 leveraged ETFs with this method using historical pricing data over the last 6 years, which includes the corrections in 2020 and 2022, and generated compound annual growth returns typically ranging from 20% to 46% range, with one fund reaching CAGR of 86%. The method I've developed (based on Lichello's original method) takes on average 15 minutes a month and is all managed from a spreadsheet I've developed, and doesn't require you to actively monitor the market activity. You can get these returns without ever logging into your brokerage account when the market is open. I designed it for the way I want to invest.
For anyone interested, I suggest you visit the AIMUSERS board and learn about this method of investing. The method is completely math-based and functions on price movement only, and doesn't use any other market or investment signal. Lots of users on that board who have utilized this method for decades. My backtesting results are published there, and I routinely share my spreadsheet with users who request it, and it includes detailed instructions on its use. Once you understand the simple process I use, it's easy to manage investments using the AIM algorithm with this spreadsheet. And all investments can be managed using a single spreadsheet.
I recently sent this spreadsheet model to a user who requested it, only to later discover she works at an Atlanta brokerage firm. I don't know if this was for her personal use or for some clients at her firm, but I do know that one poster on the board used this method to manage client assets in the past.
The method has been around since 1977 but is less known these days since Mr. Lichello's death in 2001. If you Google Lichello and AIM you will see there is still significant interest in the method, and others who are currently using it and have backtested investments using the algorithm.
This method truly takes the emotion and stress out of investing, and on average requires 10-15 minutes a month per investment to manage. All can be done on nights and weekends outside of normal market hours. I have focused my attention on AIM with 2x and 3x leveraged ETFs and have fine-tuned the algorithm settings for maximum returns depending on ETF volatility. I have also developed an effective strategy to mitigate one of the drawbacks of AIM with ETFs that have high drawdown during market corrections, that also maximizes returns on market recovery.
The Grok AI model described my method this way:
Your investment method is a sophisticated adaptation of Robert Lichello’s Automatic Investment Management (AIM) algorithm, tailored to manage a portfolio of 2x and 3x leveraged ETFs across multiple market indexes and sectors.
https://investorshub.advfn.com/A-I-M-Users-Bulletin-Board-949
All in good humor. We love losing investment money.
https://www.globenewswire.com/news-release/2023/12/22/2800853/0/en/Todos-Medical-Announces-Insolvency-Proceedings-in-Israel.html
Funniest line: "If the above plan is approved by the Court of Insolvency, the Company believes it will result in the settlement of all outstanding Todos-related liabilities and create substantial value for shareholders."
Glad to see some here following Gerald's latest ventures. I am not.
GDS is clearly still afflicting some investors.
Speaking of Gerald Derangement Syndrome... has anyone heard from JPetro lately? He recently changed his screen name to Rotten Johnny. So much for the theory a leopard never changing its spots. Has the leopard gone into hiding because there's a new predator in town?
Maybe he thought the new name would get him a discount on pizza. I wonder if he's still holding his AMBS shares on his attorney's advice.
https://rottenjohnnys.com
Gerald Commissiong is the Chief Business Officer for OS Therapies.(OSTX).
I was fortunate to have invested heavily (including what I recovered from my TOMDF shares) prior to the Sanofi partnership but have also invested afterwards. With the large short position, I've used the price swings to pick up "free" shares, which now are 23.5% of my total NVAX holdings.
I picked up 520 free shares today on a swing trade after the great earnings report. My average cost based on money I've actually invested is $4.34, and this investment has been profitable for me since my initial purchase.
I'm convinced there will be more near-term partnerships announced and a buy-out offer in 2025 or 2026 in the $100-$200 range based on what unfolds between now and then. It was GC who first turned me on to Novavax with his recommendation of their Covid vaccine. The vaccine was superior to the mRNA options and it caused me to dig deeper into the company. They had just hired a new CEO with a plan to change the strategic business model and focus on what Novavax does best, which is R&D. So far I've been impressed with all they've accomplished under that plan. Sadly, some will miss the opportunity that exists here based solely on GC's recommendation of their vaccine. Fortunately, Gerald Derangement Syndrome doesn't affect you or I or Redspeed, who is also invested in NVAX.
As a bonus, this stock is primed for a massive short squeeze. One could simply buy some shares and set a limit order for 6-10x the current share price and wait for execution. Personally, I'm holding until the buyout. With the new business model, I believe it's inevitable one of the big pharmas will want to own and control the technology for themselves.
Thanks JoeFB
I've been in Nvax for a while. kicked myself for not selling when it hit $27 then watched it tank. But I think now is likely the right time to buy more, if one has the means. It's about as low as it's likely to go, earnings were great, everything seems to be improving and likely full approval will come soon.
If anyone here who lost money on Todos has followed Novavax (NVAX), this would be a good time to invest as the news expected over the next few days, weeks and months of summer will most likely drive the share price much higher than current levels. If you doubt me, then ask yourself why Sanofi invested over a billion dollars in Novavax a year ago, and is expected to expand that partnership soon.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176106035
I realize I will get reamed for this post, and I don't care. I am invested in NVAX and I am confident I will soon recover ALL of my Todos losses. A lot is happening with NVAX over the summer and later months of 2025. Although it was GC who pointed me in the direction of Novavax, that is not the reason I invested. My hope is that at least one person who lost money in Todos can recover some of that loss by taking a position in Novavax.
As an added bonus, due to the heavy short position in Novavax, the news could trigger a short squeeze of epic proportions.
That's it. Invest and win or trash me for making the effort to help. I'm highly confident those investing in NVAX at this level will make a great return on their investment.
Same here and then declared as SPAM.
GC's credibility is like the Todos Medical (TOMDF) price ---infinitesimal
Hi. JP i hope you didnt give up. I have been getting emails from GC selling poop meds for 350 bucks under tollo health in tampa bay. Sick em tiger. I know you will. And thank you
For the few here that understand PASC and viral persistence--remember when Drs were seeing EBV reactivate in PASC patients.
And me (for example) stated there would be more chronic conditions that would be "illuminated" and the whole covid nightmare--the 1 possible benefit might be other conditions being looked at as a result of viral persistence and bad gut microbiome--instead of Drs and scientists just trying random Rx that only masks symptoms
And what shakes out--only this--https://answers.childrenshospital.org/crohns-epstein-barr/
GEEZ the wheels turn slow
Did we add another zero to the price yesterday??????
All the zeroes walked out the door.
Did this ticker add a couple of zeros in front of it while I was gone?????
TOMDF up an infinitesimal fraction today, so we got that going for us.
LONG COVID...... hmmmmmm NEVER HEARD OF IT
Thanks for signing up to reply to that post.
IF you took time to read the link--it is about long covid. If you understand PASC??
Not covid mortality or flu death.
FLU KILLING MORE PEOPLE THAN COVID reported today
https://www.latimes.com/opinion/story/2025-02-16/long-covid-research-funding
YEARS later--still waiting on trials
still waiting on Rx
Gerald Commissiong appeared on the Liz Claman Countdown, Jan. 11, 2022, so we got that going for us.
Gerald Commissiong most definitely used the Gaza war …
as an excuse for his failed Tollovid/vir scam and royal fleecing of his faithful and gullible shareholders and investors
all in an effort to fund TOMDF’s back office management under the tutelage of JF and the Astoria, Queens financial mafia
not once but twice - which was the same scam also orchestrated under his AMBS playbook
when the last TOMDF scam ran its course, JF and the boys threw Gerald under the bus as their personal scapegoat, douche bag and useful idiot hangman
but Gerald didn’t give a flying fork, as they had him greased-up like a well oiled mechanical ball bearing and tool-set flunky
Gerald is nothing more than a hack, liar, thief, and a conman - plain & simple
he and his ilk should be behind bars
must say thought that his pumpers were relentless in their efforts all on his benefit…!
AJMHO
Now that the "war" is in ceasefire, GC can renew confidence in some gullible investor(s).
He reported the main investor funding the NLC Pharma spinoff backed away when the war broke out. I'm not sure if this means the investor was from Israel, or simply didn't feel comfortable investing in the spinoff of an Israeli company during a time of war. Understandable in either case... too many uncertainties. It would be great if that investor moved forward on that front after the war is over. Tollovid and Tollovir would benefit a lot of people in the world. I hope they can figure out a way to make it happen.
I don't think he used the war as the excuse, only as a factor in the outcome. The Twitter post is copied on this board if you want to look it up. I think I'm the one who posted it. The former CEO taking the company into insolvency court over unpaid backpay he claimed was owed him is what ended this. Had the spinoff gone through, the insolvency hearing would likely have had a different outcome and the company would have survived.
The company's cash cow with Covid testing dried up as the government and hospitals moved away from testing when the government announced the pandemic was over. Covid testing of wastewater streams around the world tell a much different story, however. And Tollovid sales helped in revenues, they weren't substantial enough to make a difference. The price started at $379 per bottle and slowly worked down to $99 per bottle, probably due to both lower demand at the higher price and scaling for larger production runs to reduce cost per bottle. It was a great product and I wish I still had access to it.
I have to believe had the spinoff been successful, Todos investors would at least have had the option to exit their position little or no loss regardless of whether the company succeeded or failed afterwards.
I took a big loss here. My decision, my ownership. But I did get a nugget from GC about Novavax, and I took a large position there. I've swing traded the stock over the last 5 weeks and picked up over $40,000 in free NVAX shares. I converted the NVAX shares to my Roth account on Friday at the lowest share price since the Sanofi partnership deal was announced. No state taxes on the conversion for me, only federal. I think it will do extremely well and I expect to fully recover my Todos loss with Novavax.
I'm already testing my investment strategy beyond Novavax using leveraged ETFs and an algorithm I've studied for a long time, which in testing historical price data with a number of ETFs has shown average annual returns ranging from 35% to 68% over the most recent 5-year periods. So I'll likely be heavy into that model next. Best part is I don't have to sit in front of my computer, as I've designed it so it requires only about 15 minutes/month on average per investment. 😎
Did Gerald Commissiong use "war" as an escape hatch?
Not so sure a spinoff would have made any difference -- when expenses continuously exceed income then bankruptcy is the only option other than GC's excuse that creditors lost faith.
100%. I still have 1 unopened bottle and about half of another
The issues in Israel ruined the potential of the product alongside the thousands of lives ruined from politics/hate that seems never ending
I too hope Dr Arad finds a path to her project and gets success helping people that need a sustainable 3CL Protease Inhibitor for treatment
No argument there. I really thought this would succeed, especially with the science of Dr. Arad behind the products. Still, I wonder how this might have turned out had there been no breakout of war with Israel just prior to the planned spinoff. The NLC Pharma spinoff probably would have prevented the insolvency altogether.
Shit happens. Live and learn. I wish I still had access to Tollovid.
Agree, but Gerald Commissiong was not up to the task.
Stuart Varney gave him an excellent opportunity. TODMF shot up to 8 cents and then Long Agony took precedence over Long Covid.
It's too bad the Tollovid product didn't survive the Todos Medical insolvency. It was a product that helped a lot of Long Covid patients. It didn't work for everyone, but impacts reportedly ranged from little/no improvement to total recovery. I suspect those with little to no improvement probably took it for a short time, saw no improvement, and stopped taking it. Hindsight has shown it typically required several weeks or months of continued treatment to start to see improvements.
Tollovid was one of the approved Long Covid treatments administered by RTHM Direct, a team of degreed and licensed medical professionals whose focus is on providing a comprehensive set of treatments, labs, and guidance for complex illnesses like Long Covid, ME/CFS, MCAS and POTS. Sadly it is no longer listed as one of their treatments because when their supply was exhausted it was no longer being manufactured.
Author Alisa Valdez was the poster girl for Tollovid for a time, posting details of her serious Long Covid issues and her full recovery while taking Tollovid as a participant in a Long Covid study sponsored by Todos Medical in which she was provided free Tollovid in exchange for documenting the impact on her condition. She reported an amazing full recovery and return to a normal life, but then wound up in the hospital, and publicly blamed Tollovid. An investigation revealed she had given part of her free Tollovid supply to friends. She ran out of Tollovid and then purchased Gromwell root powder from Amazon and ingested it believing it would work the same as Tollovid. This caused liver damage that resulted in her hospitalization. Unfortunately, she blamed Tollovid for her condition after the company refused to replenish her supply of Tollovid for free. Todos revealed her actions that violated her agreement with the company and invalidated their study. She soon went silent on her claims after her actions were revealed by the Todos CEO on Twitter.
I took Tollovid on a daily basis for almost 2 years, and not only did I remain protected against Covid infections when everyone around me at work was getting infected, but also eliminated a long-standing issue with a chronic cough.
I hope Dr. Arad can find a way to get Tollovid back on the market to help Long Covid patients, and get Tollovir into a clinical trial for hospitalized Covid patients. People are still dying from Covid, so there is still a need for Tollovir over what's currently being used for treatment.
Not to worry, with that information Gerald Commissiong will make stockholders a fortune.
TOMDF stock is a steal right now.
BNO News @BNOFeed OCT 06
Weekly U.S. COVID update:
- New cases: 91,800 est.
- Average: 122,641 (-18,476)
- In hospital: 4,187 (-470)
- In ICU: 509 (-42)
- New deaths: 1,209
- Average: 1,254 (-86)
ANALYSIS: So far this year, more than 5.6 million COVID cases have been reported in the U.S., causing at least 381,888 hospitalizations (partial data) and 45,132 deaths.
Only 32.8% of hospitals in the U.S. submitted COVID data this week, which is similar to last week but down from 91% in early May. This means actual case numbers and hospitalizations are substantially higher than reported.
Thank goodness covid is over and covid is just like the flu--some levels of stupidity are amazing
Worthless??? NFL Hall of Famer Michael Irvin is an Ambassador for Tollovid
https://www.globenewswire.com/en/news-release/2022/09/16/2517590/0/en/Todos-Medical-Announces-NFL-Hall-of-Famer-Michael-Irvin-as-Tollovid-Sports-Ambassador-for-TolloUp-Campaign.html
WoW where can I buy more of those worthless TOMDF shares...?
what hooie...!
Jon Najarian interviews Gerald Commissiong (CEO Todos Medical). Looks promising for Long Covid.
What fantasy world do you live in? Good luck suing me for anything I posted. I was invested in MONI at one point for a brief period but then sold at 0.053 for a small loss. Glad I exited that pile of 💩. Even after your 500% run-up in price, it's still at 0.03. I hope this time the new merger is real and shareholders benefit, but again I ask why any entity would want to associate themselves with a company like MONI and retain their shadowy legal counsel. If I'm wrong, I'll admit it, but you're all ready to call it a glowing success with the share price only at 3 cents. Perhaps you should look at the MONI chart and see if it matches the pump-and-dump pattern you claim here. We both know the answer, don't we?
I don't recall explicitly recommending anyone sell MONI but I did post my opinion that it was a scam and has been for it's entire existence through various company name changes. Then I posted links to their corporate counsel, who has a long history of involvement with pump-and-dump companies. Can you honestly tell me you read his history and didn't have concerns? Or was your head stuck in the sand like everyone else there?
So show me the post you claim. And tell me again how anyone taking investment advice from a complete stranger on a message board is not a complete moron. I'll go one further and state that anyone who believes anyone else is responsible for their own investment choices is also a moron, and a very naive investor. I think we have a few on this board. How exactly does that work? Is it...
1. I'm a novice investor and will blindly follow advice from a stranger on a message board.
2. I'm a lazy investor and will do no DD of my own, but will accept what is posted on a message board, without question, and make my investment decisions accordingly.
3. I'm an immature person and never learned to accept responsibility for my own decisions. I find there are plenty of individuals to blame if I lose money in ANY situation in life.
You've also called Novavax a pump-and-dump. I guess that's why Sanofi invested $1.3 Billion dollars with them to license their Covid vaccine and adjuvant technology. Too bad the Sanofi team isn't as keen as you. I wonder if they looked at the stock chart. LMFAO
Here's the latest update on my Todos Medical Investment Loss Recovery Plan. I expect the overall return to change dramatically for the better by end of year as planned announcements are made. I've stopped investing my own money here but have increased my share position over the last few weeks by 13.2% by swing trading a portion of my shares. The current value of these "free" shares is $37,800. I will continue this process of accumulating free shares until the short-sellers exit the stock. And my very positive outlook and posts on the stock haven't changed one iota during the time I have been invested.
Again, thanks to GC for turning me onto the excellent Novavax Covid vaccine. Two years of protection lasting far longer than mRNA options, with zero side effects. Looking forward to the upcoming Combined Influenza-Covid vaccine and will be adding that to my annual regime.
Still waiting for the geniuses still posting here (extreme sarcasm) to explain how I'm a P&D'er. Clearly ignorance is running amuck here. Let me educate you a little.
Investopedia: How Does a Pump-and-Dump Scam Work?
A pump-and-dump scam is the illegal act of an investor or group of investors promoting a stock they hold and selling once the stock price has risen following the surge in interest as a result of their endorsement.
KEY TAKEAWAYS
• Pump-and-dump is a scheme that attempts to boost the price of a stock through recommendations based on false, misleading, or greatly exaggerated statements.
• The favored medium of communication for traders involved in pump-and-dump is social media platforms or anonymized messaging apps like Telegram and Discord.
• Promoters of the scheme will then begin to coordinate rumors, misinformation, or hype in order to artificially increase interest in the security, driving up its price.
• Then, once the price of the stock has been increased sufficiently by unsuspecting marks, the promoters then sell the stock at high prices.
It is clear the intent of a pump-and-dump scheme is to MAKE MONEY, correct? So if a person loses almost all of their investment, how are they a pump-and-dumper? I'm still waiting for the intellects here to explain that, while at the same time claiming this was a pump-and-dump stock. Seriously, answer the question. Or continue to post false claims based on ignorance and personal bias. Some here are blaming others for their losses. Some here lost in GC's previous company, Amarantus, and yet invested again. How is that anyone's fault besides your own?
I posted the news of Todos Medical's insolvency hearing in Israel. I held my shares for a few months to see how that worked out. I sold my shares over 4 days in February 2024 and posted here that I have exited my entire position. I've posted my losses and how I intend to recover those via an investment in Novavax, where I rolled the approximately $8K I recovered from my Todos shares. So once again I ask, how was this a pump-and-dump scheme and where did I profit?
Summary of my closed TOMDF positions with Fidelity, printed today. See any profits in my TOMDF sales? Time for the geniuses to step up and enlighten the board on how this was a pump-and-dump. Enlighten us.
Love it. Nice to see other people exposing them
Just pulling the chain of the P+D'ers.
Maybe the creditors will feel bad that Gerald Commissiong criticized them for not having enough confidence in his ability to prolong the inevitable.
Followers
|
131
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
20605
|
Created
|
04/25/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |